External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>PharmChem Inc. specializes in sweat-based drug testing for criminal justice customers</li><li>Faced challenges in 2021 and 2022 but has since recovered sales and announced plans for growth in 2024</li><li>Analysts predict stock price to rise from $2.91 to over $4 this year as investors re-evaluate company's prospects</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

PharmChem Inc. specializes in sweat-based drug testing for criminal justice customersFaced challenges in 2021 and 2022 but has since recovered sales and announced plans for growth in 2024Analysts predict stock price to rise from $2.91 to over $4 this year as investors re-evaluate company's prospectsThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Pharmchem Inc. (PCHM) - Thursday, Apr 11, 2024

United States

PharmChem, Inc. provides integrated drug testing services to corporate and governmental clients seeking to detect and deter the use of illegal drugs. The Company tests primarily by urinalysis, but also uses its PharmChek Drugs of Abuse Patch, which tests using collected sweat. PharmChem also offers on-site screening devices.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

PharmChem Inc (PCHM US)

Pharmchem Inc. (PCHM) - Thursday, Apr 11, 2024

PharmChem Inc. specializes in sweat-based drug testing for criminal justice customers Faced challenges in 2021 and 2022 but has since recovered...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)